InvestorsHub Logo
Followers 6
Posts 1400
Boards Moderated 0
Alias Born 08/24/2014

Re: hschlauch post# 42184

Tuesday, 11/28/2017 10:42:26 PM

Tuesday, November 28, 2017 10:42:26 PM

Post# of 48316
hschlauch, I am just speculating on the collaborator for the PIIM construct. Jounce is currently using Oncosec's GENESIS technology in pre clinical work. Do you think Jounce would be a likely partner for the new PIIM construct? They have a deep collaboration with Celgene in solid tumors. Seems logical to me that they might take more interest in Oncosec after the recent positive SITC data on the multigene construct. What is your take if any? Thanks for any insight you can give on this.